South Africa
South Africa has the largest HIV patient cohort in the world and is helping to lead the way in gaining access to new treatments for multidrug-resistant tuberculosis (MDR-TB).
In KwaZulu-Natal province, our project’s community-oriented approach is to increase integrated HIV testing and TB screening, as well as access and adherence to HIV treatment.
The Khayelitsha project near Cape Town continues to develop and implement treatment regimens for MDR-TB and innovative models of care for patients living with HIV and TB.
Our team focuses on developing models of care to support specific at-risk groups, such as pregnant women and their infants, adolescents and men.
0
21,000
0
1,430
0
550
Tuberculosis
TB drug delamanid must be more affordable and made available in more countries
Statement
10 Oct 2019
South Africa
Drivers for victims: changing lives in Rustenburg
Project Update
2 Oct 2019
HIV/AIDS
HIV project in South Africa reaches 90-90-90 target one year ahead of deadline
Press Release
12 Jun 2019
South Africa
Critical gaps in mental healthcare for survivors of sexual violence
Report
17 Dec 2018
South Africa
The mental healthcare lottery faced by victims of sexual violence
Voices from the Field
17 Dec 2018
South Africa
Country takes landmark step for access to medicines
Press Release
31 May 2018
South Africa
Responding to pervasive sexual violence in the platinum belt
Project Update
30 Nov 2017
Sexual violence
Untreated Violence: Critical gaps in medical and clinical forensic care for survivors of sexual violence in South Africa
org.za
1 Nov 2017
Access to medicines
MSF at the 48th Union World Conference on Lung Health
Event
10 Oct 2017
1999
1999
Contact us
MSF South Africa
7th Floor, Zurich House
70 Fox Street, Marshalltown
Johannesburg
South Africa